These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34186192)

  • 21. Liver X receptors in immune cell function in humans.
    Waddington KE; Jury EC; Pineda-Torra I
    Biochem Soc Trans; 2015 Aug; 43(4):752-7. PubMed ID: 26551724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of farnesylthiosalicylic acid on adjuvant-induced arthritis through suppressed release of inflammatory cytokines.
    Aizman E; Blacher E; Ben-Moshe O; Kogan T; Kloog Y; Mor A
    Clin Exp Immunol; 2014 Mar; 175(3):458-67. PubMed ID: 24215151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis.
    Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
    Biomed Pharmacother; 2018 Oct; 106():813-820. PubMed ID: 29990875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer.
    Bilotta MT; Petillo S; Santoni A; Cippitelli M
    Front Immunol; 2020; 11():584303. PubMed ID: 33224146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model.
    Chu J; Wang X; Bi H; Li L; Ren M; Wang J
    Int Immunopharmacol; 2018 Jun; 59():174-180. PubMed ID: 29656207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritis.
    Lee CT; Kokolus KM; Leigh ND; Capitano M; Hylander BL; Repasky EA
    PLoS One; 2015; 10(3):e0120327. PubMed ID: 25793532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances in the Medicinal Chemistry of Liver X Receptors.
    El-Gendy BEM; Goher SS; Hegazy LS; Arief MMH; Burris TP
    J Med Chem; 2018 Dec; 61(24):10935-10956. PubMed ID: 30004226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models to study pathogenesis and treatments of cardiac disorders in rheumatoid arthritis: Advances and challenges for clinical translation.
    Kessler J; Totoson P; Devaux S; Moretto J; Wendling D; Demougeot C
    Pharmacol Res; 2021 Aug; 170():105494. PubMed ID: 34139344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis.
    Rasheed A; Cummins CL
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis.
    Jalil A; Bourgeois T; Ménégaut L; Lagrost L; Thomas C; Masson D
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
    Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
    J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver X receptors agonists suppress NLRP3 inflammasome activation.
    Yu SX; Chen W; Hu XZ; Feng SY; Li KY; Qi S; Lei QQ; Hu GQ; Li N; Zhou FH; Ma CY; Du CT; Yang YJ
    Cytokine; 2017 Mar; 91():30-37. PubMed ID: 27987394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New biologics for rheumatoid arthritis.
    Choy E
    J R Coll Physicians Edinb; 2011 Sep; 41(3):234-7. PubMed ID: 21949922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
    Fessler MB
    Pharmacol Ther; 2018 Jan; 181():1-12. PubMed ID: 28720427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.
    A-González N; Castrillo A
    Biochim Biophys Acta; 2011 Aug; 1812(8):982-94. PubMed ID: 21193033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis.
    Wu Y; Pan W; Hu X; Zhang A; Wei W
    Biochem Pharmacol; 2021 Jan; 183():114360. PubMed ID: 33301760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.
    Beyer C; Huang J; Beer J; Zhang Y; Palumbo-Zerr K; Zerr P; Distler A; Dees C; Maier C; Munoz L; Krönke G; Uderhardt S; Distler O; Jones S; Rose-John S; Oravecz T; Schett G; Distler JH
    Ann Rheum Dis; 2015 Jun; 74(6):1317-24. PubMed ID: 24618263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism of liver X receptors in cancer therapeutics.
    Wang Q; Wang J; Wang J; Zhang H
    Life Sci; 2021 May; 273():119287. PubMed ID: 33667512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone effects of biologic drugs in rheumatoid arthritis.
    Corrado A; Neve A; Maruotti N; Cantatore FP
    Clin Dev Immunol; 2013; 2013():945945. PubMed ID: 23864880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligands of Therapeutic Utility for the Liver X Receptors.
    Komati R; Spadoni D; Zheng S; Sridhar J; Riley KE; Wang G
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28067791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.